Under the deal, Sysmex will exclusively sell Fujirebio's Lumipulse immunoassay systems and dementia-related tests in certain geographies.

The award is the first following a funding announcement last year to support typhoid fever diagnostic test development.

The firm saw a 8 decline in diagnostics revenue and projected a more pronounced decline in fiscal Q2, due primarily to volume-based pricing headwinds.

The survey of 152 clinicians also found that turnaround time and payor coverage are among the most important considerations for doctors when ordering cancer testing.

While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...

The panel is for use with Randox's Evidence MultiSTAT analyzer, which is also FDA cleared, and provides the simultaneous detection of 15 drugs of abuse — including methamphetamine, fentanyl, marijuana ...

The platform uses impedance flow cytometry to measure the electrical properties of bacteria that have been plated from a positive blood culture sample.

NEW YORK – T2 Biosystems said on Tuesday that it will immediately wind down its operations and liquidate the company.

The agency said that impurities in the company's Safe-T-Fill EDTA tubes may be related to false positive lead testing results reported by users of Magellan Diagnostics' lead detection tests.

The coalition will invest the money in six collaborative research projects focused on pancreatic, ovarian, and esophageal cancers, as well as cancer predisposition syndromes.

The 15-minute test runs on the Diasorin Liaison Nes system and obviates the need for molecular confirmation of negative rapid immunoassay results.